4523 Eisai
- 6819.0
- +55.0+0.81%
Eisai News
List of Unrivaled Stocks (Part 1) [Ichimoku Equilibrium Chart/Kumoku Stock List]
○Cloud Top Stock List Market Code Stock Name Closing Price Advance Span A Advance Span B Tokyo Stock Exchange Prime ＜1301＞ Kyokuyo 3790 3723.75 3787.5 ＜1332＞ Nissui 965 961.25 887.5 ＜1662＞ Petroleum Resources 6690 6632.5 6320 ＜1773＞ YTL
Towards next week's stock exchange rate = attention will be drawn to the US CPI, but will it continue to move forward and backward
The Nikkei Stock Average on the 10th rebounded for the first time in 3 days, and closed 155 yen higher than the previous day. It rose by over 600 yen at one point, but growth was sluggish thereafter. This day was said to be “bought with futures and sold with futures” (market participants), and there was a slight lack of direction. I was present for 4 days this week after Golden Week, but it was almost flat at 7 yen depreciation on a weekly basis. The upper price of the Nikkei Stock Average has been held at the 25-day moving average (around 38,550 yen), and the increase is heavy.
Anti-Obesity Drugs Global Strategic Business Report 2024-2030 Featuring F. Hoffmann-La Roche, GlaxoSmithKline, Eisai, Novo Nordisk, Rhythm Pharmaceuticals, and VIVUS - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Anti-Obesity Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Anti-Obesity Drugs Market to Reach $4.8 Billion b
Approximately USD 10.8 Million Invested in New Drug Development for Malaria and NTDs in Partners Including Japanese Pharma Shionogi, Mitsubishi Tanabe, and Eisai and Europe-Based Institutions
Nikkei Average Contribution Ranking (advance closing) ~ The Nikkei Average fell drastically, and Fast Rite was pushed down by about 99 yen per brand
The number of gains and falls of the Nikkei Average constituent stocks at the time of closing 8 days ago was 18 stocks with price increases, 207 stocks with price drops, and 0 stocks unchanged. The Nikkei Average fell sharply. The forward market transaction was closed at 38303.39 yen (estimated turnover of 710 million shares), which was 531.71 yen lower (-1.37%) compared to the previous day. The US stock market on the 7th was mixed. The Dow average rose by $31.99 (+ 0.08%) to $38884.26, and the Nasdaq depreciated 16.70 points (-0.10%) to 16332.5
JMDC, Shiono Yoshi, etc. (additional) Rating
Target Stock Price Change Code | Stock Name | Securities Company | Conventional | After Change |------|---------|--------|--------|＜2212＞|Yamazaki Pan | Mizuho | 3700 yen | 4150 yen |＜3064＞|Monotaro | City | 1500 yen | 1850 yen |＜4151 ＞|Kyowa Kiri
Eli Lilly Alzheimer's Therapy Set for June FDA AdCom Meeting
Nikkei Average Contribution Ranking (advance closing) ~ The Nikkei Average fell for the first time in 3 days, and Fast Rite was pushed down by about 49 yen per brand
The number of gains and falls of the Nikkei Average constituent stocks at the time of closing 1 day ago was 44 stocks with price increases, 181 stocks with price drops, and 0 stocks unchanged. The Nikkei Average fell for the first time in 3 days. The forward market transaction was closed at 38189.54 yen (estimated turnover of 880 million shares), which was 216.12 yen lower (-0.56%) compared to the previous day. The US stock market fell on April 30. The Dow average depreciated by $570.17 (-1.49%) at $37815.92, and the Nasdaq depreciated by 325.26 points (-2.04%)
Nikkei average contribution ranking (advance closing) ~ The Nikkei Average rebounded, and TOEREC boosted by about 61 yen with 1 brand
The number of gains and falls of the Nikkei Average constituent stocks as of closing 26 days ago was 121 stocks with a price increase and 101 stocks with a price drop of 3 stocks unchanged. The Nikkei Average rebounded. The front-end transaction was closed at 37780.35 yen (estimated volume of 740 million shares), which was 151.87 yen higher (+0.40%) compared to the previous day. The US stock market declined on the 25th. The Dow average depreciated by 375.12 dollars (-0.98%) at 38085.80 dollars, and the NASDAQ depreciated 100.99 points (-0.64%) at 15611.
Brands that moved the day before part 1 Japan Aviation Electronics Industry, CUC, Metawater, etc.
<コード>Stock name closing price on the 25th ⇒ Hulic ＜3003＞ 1424.5 -63.5 1st quarter operating profit decreased 30.5% compared to the previous day. Marubeni Leasing ＜9763＞ 3065 +10924 financial results and dividend forecasts for the fiscal year ending March 31, 24 were revised upward. Ishizuka Nitro ＜5204＞ operating profit for the fiscal year ending 2682 -16525 is expected to decrease 54.2%. Daiichi Sankyo ＜4568＞ 4766 +37 share buying/cancellation with an upper limit of 2.87% of the number of issued shares. Business is growing but stock prices are sluggish. No. 1<
Movements to avoid risk due to concerns about the performance of Japanese and American companies
The Nikkei Average fell sharply. The transaction closed at 37628.48 yen (estimated turnover of 1.59 billion shares), which depreciated by 831.60 yen. Profit-taking sales took precedence from the reaction that had risen by over 900 yen the day before. Also, the fact that US Meta Platforms, which showed a sluggish earnings forecast, was plummeting overtime worsened investor sentiment, and performance unease of domestic high-tech companies was also alarmed, and the Nikkei Average remained soft throughout the day. The fact that US stock index futures continue to be soft also strengthens the buy-off attitude
The Nikkei Average depreciates by 855 yen, and there is interest in corporate financial results and US economic indicators
The Nikkei Average depreciated by 855 yen (as of 14:40). In terms of the Nikkei average contribution, First Rate ＜9983＞, East Elec ＜8035＞, Shin-Etsu ＜4063＞, etc. are top negative contributors, while Eisai ＜4523＞, Daikin ＜6367＞, Daiichi Sankyo ＜4568＞, etc. are top positive contributors. All industries have dropped in price in the sector. The electric/gas industry, mining industry, real estate industry, electrical equipment, and transportation equipment are at the top of the price drop rate. The Nikkei Average has declined widely
Front market [stocks that have moved, stocks that have been created]
*Japan Aviation Electronics Industry＜6807＞ 2548 +217 The profit forecast for the current fiscal year exceeds market expectations. *Ordinary income forecasts were revised upward due to large vacuum ＜6962＞ 827 +44 exchange margin recording, etc. *Are Capcom ＜9697＞ 2636 +73.5 evoJapan upcoming events also expected. *Is it a supply-demand factor, such as buybacks in the high price range of NIPPATS ＜5991＞ 1584 +44? *Eisai ＜4523＞ No. 6244 +155 Alzheimer's drug “Rekenbi”
Nikkei Average Contribution Ranking (advance closing) ~ The Nikkei Average fell drastically for the first time in 4 days, and Fast Rite was pushed down by about 126 yen per brand
The number of gains and falls of the Nikkei Average constituent stocks as of closing 25 days ago was 32 stocks with price increases, 193 stocks with price drops, and 0 stocks unchanged. The Nikkei Average fell sharply. The forward transaction was closed at 37818.11 yen (estimated turnover of 790 million shares), 641.97 yen lower (-1.67%) compared to the previous day. The US stock market was mixed on the 24th. The Dow average depreciated by 42.77 dollars (-0.11%) to 38460.92 dollars, and the Nasdaq rose 16.11 points (+ 0.10%) to 15712
3 points to pay attention to in the aftermath - stocks announced financial results have been sold and investor sentiment worsens
I would like to pay attention to the following 3 points in the late-day transaction on the 25th. ・The Nikkei Average fell drastically, and investor sentiment deteriorated due to sales of stocks announcing financial results · The dollar and yen were slightly higher in the 155 yen range; the top contributor to price drops was First Rate ＜9983＞, and the same 2nd place was Tokyo Electron ＜8035＞■The Nikkei Average fell drastically, stocks announced financial results were sold, and investor sentiment deteriorated, and the Nikkei Average fell drastically. 37818.11 yen (-1.67%) lower than the previous day (estimated turnover 790 million)
The Nikkei Average fell drastically, stocks announced financial results were sold, and investor sentiment worsened
The Nikkei Average fell sharply. The forward transaction was closed at 37818.11 yen (estimated turnover of 790 million shares), 641.97 yen lower (-1.67%) compared to the previous day. The US stock market was mixed on the 24th. The Dow average closed at 38460.92 dollars with a depreciation of 42.77 dollars (-0.11%), the Nasdaq closed at 15712.75 with a 16.11 point increase (+ 0.10%), and the S&P 500 closed at 5071.63 with a 1.08 point increase (+ 0.02%). Semiconductor manufacturer Te
Biogen/Eisai's Popular Alzheimer's Drug Leqembi Is Seeing Slow Adoption - Here's Why
Nine months after the U.S. launch of Eisai Limited (OTC:ESALY) and Biogen Inc's (NASDAQ:BIIB) Leqembi, the first drug shown to slow Alzheimer's progression, adoption faces hurdles due to skepticism am
Alzheimer's Drug Leqembi Finally Sees Sales Pickup -- WSJ
By Peter Loftus Sales of a groundbreaking new Alzheimers disease treatment from Eisai and Biogen are finally accelerating, after a sluggish launch last year. Biogen said Wednesday that the number of
Biogen Says Uptake for Alzheimer's Therapy Is Improving
Sales revenue (preliminary report) of the anti-amyloid beta protofibril antibody “Recembi”
2024/4/24 for printing Eisai Co., Ltd. (Headquarters: Tokyo; Representative Executive Officer and CEO: Haruo Naito) is announcing that global sales revenue for the fourth quarter of fiscal 2023 (2024/1/1/1-3/31) of the anti-amyloid beta protofibrils antibody “Recembi” was 2.83 billion yen (pre-audit value), which was approximately 2.7 times higher than the previous quarter (2023/10/1 to 12/31). This information is from today's Biogen Ink (headquarters:
Analysis
Price Target
No Data
